It remains to be determined whether different functional inhibitors of acid sphingomyelinase act on the acid sphingomyelinase/ceramide system and additional targets that are also important for infection, thereby amplifying the effects of the drugs used against the infection. The gene discussed is SMPD1; the disease is infection.